Additionally, a study revealed that high expression of LRPPRC was positively correlated with a favorable prognosis for gliomas, but increased expression of RPN1 and GYS1 was associated with an unfavorable prognosis (Guo et al., 2023). Here, GYS1 is linked to central nervous system cancer.